Paracrine stimulation of capillary endothelial cell migration by endometrial tissue involves epidermal growth factor and is mediated via up-regulation of the urokinase plasminogen activator receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 4, 2001, Pages 1724-1730

  Sandberg, Tove ^a   Ehinger, Anna ^a   Casslén, Bertil ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FIBROBLAST GROWTH FACTOR; UROKINASE RECEPTOR; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXPLANT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MIGRATION INHIBITION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 0035035008     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.4.7425     Document Type: Article

References (49)

1. Vascular endothelial growth factor expression in cycling human endometrium
2. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: Localization and expression of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased GFG-R1 expression in menorrhagia
3. 1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1
4. Expression of platelet-derived endothelia cell growth factor and its mRNA in uterine endometrium during the menstrual cycle
5. Immunohistochemical localization of epidermal growth factor in human endometrium, decidua, and placenta
6. Changes in epidermal growth factor receptor and the levels of the ligands during menstrual cycle in human endometrium
7. Regulation of integrin function by the urokinase receptor
8. Integrin signaling: Cytoskeletal complexes, MAP kinase activation, and regulation of gene expression
9. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling
10. Occurrence of both urokinase and tissue plasminogen activator in the human endometrium
11. Hormonal regulation of the release of plasminogen activators and of a specific activator inhibitor from endometrial tissue in culture
12. Plasminogen activators in the human endometrium, cellular origin and hormonal regulation
13. Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor (PAI-1) and surface expression of the u-PA receptor
14. Human endothelial cell migration is stimulated by urokinase plasminogen activator: Plasminogen activator inhibitor-1 complex released from endometrial stromal cells stimulated with transforming growth factor β1; possible mechanism for paracrine stimulation of endometrial angiogenesis
15. Dating the endometrial biopsy
16. Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis
17. Invasion of cytotrophoblastic (JEG-3) cells is up-regulated by interleukin-15 in vitro
18. CD9 participates in endothelial cell migration during in vitro wound repair
19. Different mechanisms are involved in the antibody mediated inhibition of ligand to the urokinase receptor or: A study based on biosensor technology
20. The receptor for urokinase-type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes
21. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity
22. Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration
23. Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro
24. Upregulation of urokinase receptor expression on migrating endothelial cells
25. Plasminogen activators are involved in keratinocyte and fibroblast migration in wounded cultures in vitro
26. Inhibition of urokinase synthesis and cell surface binding alters the motile behavior of embryonic endocardial-derived mesenchymal cells in vitro
27. The plasmmogen activation system in tumor growth invasion, and metastasis
28. 2-macroglobulin receptor
29. Growth factor activation of MAP kinase requires cell adhesion
30. Cell anchorage permits efficient signal transduction between ras and its downstream kinases
31. 3 integrin associates with activated insulin and PDGFβ receptors and potentiates the biological activity of PDGF
32. 2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor
33. Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activation protein-2-α-related factor
34. Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1
35. Proliferation kinetics of human endometrium during the normal menstrual cycle
36. Endothelial cell migratory signal produced by human endometrium during the menstrual cycle
37. Endometrial endothelial cell proliferation during the menstrual cycle
38. Angiogenic activity in normal and dysfunctional uterine bleeding human endometrium: As measured by the chick chorioallantoic membrane assay
39. Menstruation in intraocular endometrial transplants in the rhesus monkey
40. The effects of natural and synthetic sex steroids on human decidual endothelial cell proliferation
41. Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid
42. Endometrial expression of mRNA encoding epidermal growth factor receptor in normal and leiomyomatous uteri throughout the menstrual cycle
43. In vivo estrogen regulation of epidermal growth factor receptor in human endometrium
44. Cyclic changes in epidermal growth factor receptor in human endometrium during menstrual cycle
45. Suppression of integrin activation: A novel function of a Ras/Raf-initiated MAP kinase pathway
46. Angiostatic activities of medroxyprogesterone acetate and its analogues
47. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium
48. Mechanisms of angiogenesis